Company Filing History:
Years Active: 1998
Title: The Innovations of Cataline M Garanchon
Introduction
Cataline M Garanchon is a notable inventor based in Northridge, California. He has made significant contributions to the field of medical technology, particularly in the development of fibrinogen-containing compositions. With a total of two patents to his name, Garanchon has demonstrated a commitment to advancing healthcare solutions.
Latest Patents
Garanchon's latest patents include a method of preparing a topical fibrinogen complex. This innovative method involves preparing a fibrinogen-containing composition derived from human plasma by separating a cryoprecipitate from the plasma. The process includes suspending the cryoprecipitate in a salt-containing buffer and treating the supernatant through affinity-chromatography on a lysine-bound solid matrix. This allows plasminogen to adsorb, leading to the collection of a fraction containing less than 10 µg/ml plasminogen, which is then treated to reduce viral activity. The resulting fibrinogen-containing composition is advantageous as it contains such a low amount of plasminogen that no addition of fibrinolysis inhibitor is needed. Additionally, he has developed a topical fibrinogen complex that, upon reacting with thrombin, functions as a fibrin sealant. This composition is characterized by being free of detectable levels of lipid enveloped virus activity, free of prothrombin complex and active thrombin, and contains no protease inhibitors or other non-human proteins.
Career Highlights
Garanchon is currently employed at Baxter International Inc., a leading company in the healthcare sector. His work focuses on innovative solutions that enhance patient care and safety. His contributions have been instrumental in the development of advanced medical products that address critical health needs.
Collaborations
Some of his notable coworkers include Daphne C Tse and Samia S Mankarious. Their collaborative efforts contribute to the innovative environment at Baxter International Inc., fostering advancements in medical technology.
Conclusion
Cataline M Garanchon is a distinguished inventor whose work in developing fibrinogen-containing compositions has the potential to significantly impact medical treatments. His patents reflect a dedication to improving healthcare solutions, and his role at Baxter International Inc. underscores his commitment to innovation in the medical field.